DPDPE ([D-Pen2,D-Pen5]enkephalin) is a synthetic opioid peptide and a selective agonist of the δ-opioid receptor (DOR) which is used in scientific research.[1] It was developed in the early 1980s and was the first highly selective agonist of the DOR to be developed.[1] It was derived from structural modification of met-enkephalin.[2]
Clinical data | |
---|---|
Other names | L-Tyrosyl-D-penicillamyl-glycyl-L-phenylalanyl-D-penicillamine (2->5)-disulfide; H-Tyr-D-Pen(1)-Gly-Phe-D-Pen(1)-OH |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
ChEBI |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C30H39N5O7S2 |
Molar mass | 645.79 g·mol−1 |
3D model (JSmol) |
|
| |
|